Corcept Therapeutics | CORT - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Acadia Pharmaceuticals USD 272.68M 6.08M 2026-03
Alaunos Therapeutics USD 1.01M 175K 2026-03
ANI Pharmaceuticals USD 562.3M 344.37M 2026-03
Ardelyx USD 127.27M 7.15M 2026-03
Aurora Cannabis CAD 48.04M 81.94M 2026-03
BioMarin Pharmaceutical USD 636.56M 39.61M 2026-03
Bristol-Myers Squibb USD 20.07B 11.77B 2026-03
Canopy Growth CAD 98.72M 11.51M 2026-03
Corcept Therapeutics USD 214.5M 16.87M 2026-03
Eli Lilly USD 10.02B 285M 2026-03
Esperion Therapeutics USD 83.21M 14.06M 2025-12
J&J USD 17.44B 1.53B 2026-03
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Lexicon Pharmaceuticals USD 20.27M 6.1M 2025-12
Merck USD 18.17B 8.01B 2026-03
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Novartis USD 9.29B 507M 2026-03
Novartis USD 9.29B 507M 2026-03
Omeros USD 59.16M 20.13M 2024-06
Pacira USD 172.75M 20.93M 2026-03
Pfizer USD 90.1B 77.19B 2026-03
Supernus Pharmaceuticals USD 1.08B 879.06M 2026-03
TG Therapeutics USD 170.12M 28.04M 2026-03